12 news items
Nurix Therapeutics Announces Board Chair Transition
NRIX
20 May 24
has been instrumental in our growth from a private, ligase research company to a public, drug discovery and development company with three innovative
Nurix Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference
NRIX
7 May 24
is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative small molecules and antibody
Nurix Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
NRIX
16 Apr 24
of innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
NRIX
11 Apr 24
of innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer
Nurix Therapeutics Announces Proposed Public Offering
NRIX
11 Apr 24
biopharmaceutical company focused on the discovery, development and commercialization of innovative small molecules and antibody therapies based
vmk34ft2
NRIX
9 Apr 24
, development and commercialization of innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel
n709giixh54c06p5hoiy
NRIX
2 Apr 24
focused on the discovery, development and commercialization of innovative small molecules and antibody therapies based on the modulation of cellular protein
dwtne89tlwd1el8ldcsjkt6skfc07g1heep n9ziovpyej
NRIX
25 Mar 24
Research UK, whose goal is to facilitate identification of the greatest challenges in cancer today and to fund global teams to work in innovative ways
548p52
NRIX
20 Mar 24
Presentation highlights Nurix's innovation and leadership in targeted protein modulation, including ligase inhibition
pmbpxez73aaem9jqxe5auubp7ybojuiag56n
NRIX
20 Mar 24
Nurix's innovation and leadership in targeted protein modulation, including ligase inhibition Unique
4f9qq1x6uuof mb6sa45zjdfc51
NRIX
11 Mar 24
of innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer
0cpf0kk7ibn845h0m0hxpj80r8g905 ydh
NRIX
6 Mar 24
Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative
- Prev
- 1
- Next